Skip to content

OptimizeRx OPRX Total costs & expenses

Total costs & expenses at other companies

Phreesia logo
PhreesiaPHR
$124.19M+4.2%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
$180M+0.2%
National Research Corporation logo
National Research CorporationNRC
$28.7M+6.4%
Fluent, Inc. logo
Fluent, Inc.FLNT
$48.76M-21.7%
Quad Graphics logo
Quad GraphicsQUAD
$563.3M-7.6%
UnitedHealth Group logo
UnitedHealth GroupUNH

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's total costs & expenses?
OptimizeRx (OPRX) reported total costs & expenses of $19.45M in Q1 2026.